NasdaqGM:TNDMMedical Equipment
The Bull Case For Tandem Diabetes Care (TNDM) Could Change Following Mobi-T Pump And App Milestones - Learn Why
Baird recently upgraded Tandem Diabetes Care to Outperform after the company reported third-quarter 2025 revenues above forecasts, maintained its full-year US$1.00 billion guidance, and advanced its product ecosystem with FDA clearance for the Android version of its Tandem Mobi app and plans for a mid-2026 Mobi-T insulin pump launch.
These developments highlight how Tandem is leaning on product innovation and expanding digital accessibility to support its insulin pump platform and recurring...